Pfizer (PFE) reported Q1 FY2023 earnings of $1.23 per share (versus $1.62 per share in Q1 FY2022), beating analysts’ consensus estimate of $0.99 per share.
The company’s quarterly revenues amounted to $18.282 bln (-28.8% y/y), beating analysts’ consensus estimate of $16.488 bln.
PFE rose to $39.70 (+1.25%) in pre-market trading.
